GILEAD SCIENCES, INC. Proceeds from Stock Issuance 2007-2026 | GILD
Beta
What is GILEAD SCIENCES, INC.'s current proceeds from stock issuance?
GILEAD SCIENCES, INC. (GILD) annual proceeds from stock issuance for 2025 was $408.0M, a 3.32% decline from 2024. GILEAD SCIENCES, INC. proceeds from stock issuance for the quarter ending March 31, 2026 was $166.0M.
What was GILEAD SCIENCES, INC.'s proceeds from stock issuance in 2024?
GILEAD SCIENCES, INC. annual proceeds from stock issuance for 2024 was $422.0M, a 81.90% increase from 2023.
What was GILEAD SCIENCES, INC.'s proceeds from stock issuance in 2023?
GILEAD SCIENCES, INC. annual proceeds from stock issuance for 2023 was $232.0M, a 24.92% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year proceeds from stock issuance CAGR?
GILEAD SCIENCES, INC. proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 9.77% from FY2020 to FY2025, going from $256.0M to $408.0M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+9.8%
FY2020
$256.0M
→
FY2025
$408.0M
07080910111213141516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $408.0M | -3.3% | 10-K |
| FY2024 | $422.0M | +81.9% | 10-K |
| FY2023 | $232.0M | -24.9% | 10-K |
| FY2022 | $309.0M | +82.8% | 10-K |
| FY2021 | $169.0M | -34.0% | 10-K |
| FY2020 | $256.0M | +22.5% | 10-K |
| FY2019 | $209.0M | -27.7% | 10-K |
| FY2018 | $289.0M | +23.5% | 10-K |
| FY2017 | $234.0M | +12.5% | 10-K |
| FY2016 | $208.0M | -34.8% | 10-K |
| FY2015 | $319.0M | -3.6% | 10-K |
| FY2014 | $331.0M | +5.8% | 10-K |
| FY2013 | $313.0M | -32.8% | 10-K |
| FY2012 | $466.0M | +120.1% | 10-K |
| FY2011 | $211.7M | -4.3% | 10-K |
| FY2010 | $221.2M | -0.7% | 10-K |
| FY2009 | $222.7M | -9.5% | 10-K |
| FY2008 | $246.1M | +1.1% | 10-K |
| FY2007 | $243.4M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →